AMD Advanced Micro Devices Inc.

AMD Collaborates with The Energy Sciences Network on Launch of its Next-Generation, High-Performance Network to Enhance Data-Intensive Science

AMD Collaborates with The Energy Sciences Network on Launch of its Next-Generation, High-Performance Network to Enhance Data-Intensive Science

— ESnet6 leverages AMD adaptive networking technology for packet monitoring at extremely high transfer rates and to allow for continuous innovation in the network —

SANTA CLARA, Calif., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Today (NASDAQ: AMD) announced its collaboration with the Energy Sciences Network (ESnet) on the launch of ESnet6, the newest generation of the U.S. Department of Energy’s (DOE’s) high-performance network dedicated to science.

AMD worked closely with ESnet since 2018 to integrate powerful adaptive computing for the smart and programmable network nodes of ESnet6. ESnet6’s extreme scale packet monitoring system uses AMD Alveo™ U280 FPGA-based network-attached accelerator cards at the core network switching nodes. This will enable high-touch packet processing and help improve the accuracy of network monitoring and management to enhance performance. The programmable hardware allows for new capabilities to be added for continuous innovation in the network.

In order to customize AMD Alveo U280 2x100Gb/s accelerators as network interface cards (NIC) for ESnet6, the OpenNIC overlay – developed by AMD – was used to provide standard network-interface and host-attachment hardware, allowing novel and experimental networking functions to be implemented easily on the Alveo card. OpenNIC has since been open-sourced after being successfully used and evolved by ESnet, as well as various leading academic research groups. Also important for rapid innovation by non-hardware experts was the use of the AMD VitisNetP4 development tools for compiling the P4 packet processing language to FPGA hardware.

AMD Alveo U280 cards, using OpenNIC and VitisNetP4, are being deployed on every node of the ESnet6 network. The high-touch approach based on FPGA-accelerated processing allows every packet in the ESnet6 network to be monitored at extremely high transfer rates to enable deep insights into the behavior of the network, as well as helping to rapidly detect and correct problems and hot spots in the network. The Alveo U280 card with OpenNIC platform also supplies the adaptability to allow the continuous roll-out of new capabilities to the end user community as needs evolve over the lifetime of ESnet6.

The benefits of AMD adaptive computing at demanding network line rates are also applied to the edges of the ESnet6 network. Globally distributed scientific instruments are the primary sources of the “big data” science flows that ESnet must support. The Alveo card with OpenNIC can be used for customized data filtering and shaping before transmission over ESnet. For supercomputing facilities, which are among the destinations for these large data sets, the Alveo card with OpenNIC can be used for load balancing across compute and storage servers.

“AMD is honored to provide ESnet with leading-edge technology and expertise needed to help bring the new network into service,” said Ivo Bolsens, senior vice president and CTO of Adaptive and Embedded Computing Group, at AMD. “AMD FPGA-based adaptive networking capabilities make up a core building block of the ESnet6 extreme-scale packet processing system and provide the underpinning for the DOE’s future vision of distributed e-science.”

High-capacity, high-performance networking

Headquartered at Lawrence Berkeley National Laboratory (Berkeley Lab), ESnet serves as the “data circulatory system” for the DOE, connecting all of its national laboratories, and tens of thousands of DOE-funded researchers. This includes DOE’s premier scientific instruments and supercomputer centers – including the world’s first exascale system, the powered by AMD EPYC™ CPUs and AMD Instinct™ Accelerators.

“ESnet6 is built to support the DOE’s multi-billion-dollar investment in scientific research that leads to breakthroughs that impact our everyday lives. It represents a transformational change in the way networks are built for scientific research,” said Inder Monga, executive director of ESnet. “AMD’s technology helps us enhance the resiliency, flexibility and performance of the network.”

With over 46 Terabits per second of bandwidth, ESnet6 features a significant increase in bandwidth over prior generations to support unique needs of scientific research. With this boost in capacity, along with new service capabilities, scientists can more quickly process, analyze, visualize, share, and store the mountains of research data produced by experiments, modeling and simulations. Data rapidly moves between the interconnected sites and collaborators, accelerating time to discovery.

Supporting Resources 

  • Learn more about
  • Read about and
  • Learn more about and
  • Become a fan of AMD on 
  • Follow AMD on 

About AMD 

For more than 50 years AMD has driven innovation in high-performance computing, graphics and visualization technologies. Billions of people, leading Fortune 500 businesses and cutting-edge scientific research institutions around the world rely on AMD technology daily to improve how they live, work and play. AMD employees are focused on building leadership high-performance and adaptive products that push the boundaries of what is possible. For more information about how AMD is enabling today and inspiring tomorrow, visit the AMD (NASDAQ: AMD) , , and pages.

AMD, the AMD Arrow logo, Alveo, EPYC, AMD Instinct, Xilinx and combinations thereof are trademarks of Advanced Micro Devices, Inc. Other names are for informational purposes only and may be trademarks of their respective owners

Contact:

Brian Garabedian

AMD Communications



(408) 386-4621

Suresh Bhaskaran

 AMD Investor Relations

(408) 749-2845



EN
11/10/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Advanced Micro Devices Inc.

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NKTR NEKTAR THERAPEUTICS
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
GERN GERON CORP.
FB FACEBOOK INC. CLASS A
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
BCRX BIOCRYST PHARMACEUTICALS INC.
AXTI AXT INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
ACRS ACLARIS THERAPEUTICS INC.
CDR CD PROJEKT S.A.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
EA ELECTRONIC ARTS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
OVID OVID THERAPEUTICS
ISR ISORAY
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
STRO SUTRO BIOPHARMA
UBER UBER TECHNOLOGIES INC.
STOK STOKE THERAPEUTICS
SMCI SUPER MICRO COMPUTER
IDYA INC.
PASG IDEAYA BIOSCIENCES
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
KROS ADICET BIO INC
ORIC KEROS THERAPEUTICS
ZNTL ORIC PHARMACEUTICALS
BEAM ZENTALIS PHARMACEUTICALS
LRMR BEAM THERAPEUTICS
PRAX LARIMAR THERAPEUTICS INC
U PRAXIS PRECISION MEDICINES
TVTX UNITY SOFTWARE
VRDN TRAVERE THERAPEUTICS INC
SANA VIRIDIAN THERAPEUTICS INC
PLTK SANA BIOTECHNOLOGY
RBLX PLAYTIKA HOLDING
DAWN ROBLOX
STX DAY ONE BIOPHARMACEUTICALS INC
APP SEAGATE TECHNOLOGY HLDGS PLC
GFS APPLOVIN CORP
GMTX GLOBALFOUNDRIES INC
TYRA GEMINI THERAPEUTICS INC
PEPG TYRA BIOSCIENCES INC
EWTX PEPGEN INC
SLDB EDGEWISE THERAPEUTICS INC
DDI SOLID BIOSCIENCES INC
APGE DOUBLEDOWN INTERACTIVE CO LTD
EMBRAC B APOGEE THERAPEUTICS INC
DNTH EMBRACER GROUP AB
ORKA DIANTHUS THERAPEUTICS INC
BCAX ORUKA THERAPEUTICS INC
ZBIO BICARA THERAPEUTICS INC.
TLX ZENAS BIOPHARMA INC.
MAZE TELIX PHARMACEUTICALS LIMITED
JBIO MAZE THERAPEUTICS INC
IMA JADE BIOSCIENCES INC
IMAGENEBIO INC.
Pierre FerraguÊ
  • Pierre FerraguÊ

The Tech Infrastructure Quarterly Bible 4Q25

​​​​We publish today our comprehensive quarterly bible: 243 pages of detailed analyses on what happened in the last 3 months, and how we interpret it, in light of our current convictions. The first section acts as a PM summary, outlining our key findings, and latest thoughts on the semi cycle, in 6 slides:

ResearchPool Subscriptions

Get the most out of your insights

Get in touch